Sarah W.S. Ng

Deep whole-genome ctDNA chronology of treatment-resistant prostate cancer

Cameron Herberts, Matti Annala, Joonatan Sipola et al. · Nature · 2022 · 192 citations

Medicine, Molecular Biology, Oncology +12

Prediction of plasma ctDNA fraction and prognostic implications of liquid biopsy in advanced prostate cancer

Nicolette M. Fonseca, Corinne Maurice‐Dror, Cameron Herberts et al. · Nature Communications · 2024 · 120 citations · Full text

Medicine, Biostatistics, Oncology +17

The 5-Hydroxymethylcytosine Landscape of Prostate Cancer

Martin Sjöström, Shuang G. Zhao, Samuel Levy et al. · Cancer Research · 2022 · 67 citations · Full text

Medicine, Molecular Biology, Oncology +17

Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer

Sofie H. Tolmeijer, Emmy Boerrigter, Takayuki Sumiyoshi et al. · Clinical Cancer Research · 2023 · 56 citations · Full text

Medicine, Oncology, Pharmacology +17

Multiregion sampling of de novo metastatic prostate cancer reveals complex polyclonality and augments clinical genotyping

Evan W. Warner, Kim Van der Eecken, Andrew J. Murtha et al. · Nature Cancer · 2024 · 45 citations

Medicine, Oncology, Urology +14